Track Nephros, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nephros, Inc. NEPH Open Nephros, Inc. in new tab

3.68 USD
P/E
52.57
EPS
0.07
P/B
3.84
ROE
7.76
Beta
1.47
Target Price
7.00 USD
Nephros, Inc. logo

Nephros, Inc.

🧾 Earnings Recap – Q3 2025

Nephros, Inc. delivered strong third-quarter results with $4.8 million in revenue, marking a 35% year-over-year increase and achieving profitability for the fifth consecutive quarter.

  • Record $4.8 million in revenue driven by growth in programmatic and service offerings.
  • Five consecutive quarters of profitability with net income rising to $337,000.
  • Strong gross margins maintained at 61%, despite increased inventory handling expenses.
  • Active customer sites exceeded 1,650, consistent with expanding market presence.
  • Positive cash flow from operations improved by $722,000 year-over-year.
📅
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E52.57
EPS0.07
Book Value0.96
Price to Book3.84
Debt/Equity9.05
% Insiders11.102%
Growth
Revenue Growth0.07%
Earnings Growth-0.80%
Estimates
Forward P/E36.80
Forward EPS0.10
Target Mean Price7.00

DCF Valuation

Tweak assumptions to recompute fair value for Nephros, Inc. (NEPH)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nephros, Inc. Logo Nephros, Inc. Analysis (NEPH)

United States Health Care Official Website Stock

Is Nephros, Inc. a good investment? Nephros, Inc. (NEPH) is currently trading at 3.68 USD. Market analysts have a consensus price target of 7.00 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 52.57. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Nephros, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 0.10.

Investor FAQ

Does Nephros, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nephros, Inc.?

Nephros, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.07.

Company Profile

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Exchange Ticker
NMS (United States) NEPH

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
March 17, 2011 0.050000
July 10, 2019 0.110000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion